SCHEMBL5348902

SCHEMBL5348902

Cc1cc(Nc2cccc(C(=O)NCCC(C)(C)N)c2)c2ccccc2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.64
MAPT P10636 2/20 0.53
GUSB P08236 1/20 0.53
HTT P42858 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TSHR P16473 1/20 0.50
RAD52 P43351 1/20 0.49
DNMT1 P26358 3/20 0.48
DNMT3A Q9Y6K1 3/20 0.48
EHMT1 Q9H9B1 2/20 0.48
DNMT3L Q9UJW3 2/20 0.48
OPRK1 P41145 1/20 0.47
HDAC4 P56524 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
SIRT2 Q8IXJ6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5351482 0.93 NPC1 (0.60) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4633366 0.89 NPC1 (0.67) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4828232 0.87 NPC1 (0.67) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4632753 0.85 NPC1 (0.62) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4632702 0.85 NPC1 (0.65) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4828131 0.83 HTT (0.64) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4832178 0.83 NPC1 (0.62) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4833960 0.83 NPC1 (0.62) NPC1MAPTGUSBHTTKDM4E
SCHEMBL4632730 0.83 NPC1 (0.62) NPC1MAPTGUSBHTTKDM4E
SCHEMBL5348906 0.83 NPC1 (0.65) NPC1MAPTGUSBHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265122-B2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed